The two-receptor system PAR-1/PAR-4 mediates α-thrombin-induced [Ca2+]i mobilization in human astrocytoma cells

被引:50
作者
Kaufmann, R
Patt, S
Zieger, M
Kraft, R
Tausch, S
Henklein, P
Nowak, G
机构
[1] Univ Jena, Res Grp Pharmacol Hemostaseol, Fac Med, D-07747 Jena, Germany
[2] Univ Jena, Inst Pathol Neuropathol, Fac Med, D-07747 Jena, Germany
[3] Univ Jena, Div Pediat Oncol & Hematol, Fac Med, D-07747 Jena, Germany
[4] Humboldt Univ, Fac Med Charite, Inst Biochem, D-10098 Berlin, Germany
关键词
proteinase-activated receptors; PAR-1; PAR-4; astrocytoma cells; calcium;
D O I
10.1007/PL00008481
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proteinase-activated receptor 1 (PAR-1) was characterized as a functional receptor for thrombin in cells from different brain tumor entities. Whether PAR-1 alone accounts for thrombin-induced effects in human cancer cells, or whether other PAR contribute is unknown. We established primary cultures from two neurosurgically removed human astrocytomas and investigated intracellular signaling roles of PAR-1 and PAR-4 by estimating the effect of alpha-thrombin and PAR-activating peptides on [Ca2+](i) mobilization in single astrocytoma cells. alpha-Thrombin or the PAR-1-activating peptide SFLLRN induced a transient calcium mobilization. This suggests the involvement of PAR-1 in alpha-thrombin-induced calcium signaling in human astrocytoma cells. In addition, a second, PAR-4-dependent, mechanism exists. This was deduced from the findings that a further calcium signal could be observed in human astrocytoma cells stimulated with alpha-thrombin after SFLLRN and the PAR-4-activating peptide GYPGQV also induced a calcium response. In addition, the observation that trypsin, known to activate both PAR-2 and PAR-4, but not the specifically PAR-2-activating peptide SLIGRL induced calcium signaling is a further indication of functional PAR-4-type thrombin receptors in human astrocytoma cells. This is the first report demonstrating a signaling role for a dual thrombin receptor system in human tumor cells.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 17 条
[1]   Cytosolic phospholipase A(2) is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: Characterization of the transducing mechanism [J].
Bayon, Y ;
Hernandez, M ;
Alonso, A ;
Nunez, L ;
GarciaSancho, J ;
Leslie, C ;
Crespo, MS ;
Nieto, ML .
BIOCHEMICAL JOURNAL, 1997, 323 :281-287
[2]  
BERNDT M, PLATELETS BIOL PATHO, V198, P43
[3]   A RANDOMIZED TRIAL OF ANTICOAGULATION WITH WARFARIN AND OF ALTERNATING CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER BY THE CANCER AND LEUKEMIA GROUP-B [J].
CHAHINIAN, AP ;
PROPERT, KJ ;
WARE, JH ;
ZIMMER, B ;
PERRY, MC ;
HIRSH, V ;
SKARIN, A ;
KOPEL, S ;
HOLLAND, JF ;
COMIS, RL ;
GREEN, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :993-1002
[4]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[5]   THE USE OF ANTIAVIDIN ANTIBODY AND AVIDIN - BIOTIN - PEROXIDASE COMPLEX IN IMMUNOPEROXIDASE TECHNIQUES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1981, 75 (06) :816-821
[6]   Protease-activated receptor 3 is a second thrombin receptor in humans [J].
Ishihara, H ;
Connolly, AJ ;
Zeng, DW ;
Kahn, ML ;
Zheng, YW ;
Timmons, C ;
Tram, T ;
Coughlin, SR .
NATURE, 1997, 386 (6624) :502-506
[7]   Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin [J].
Kahn, ML ;
Nakanishi-Matsui, M ;
Shapiro, MJ ;
Ishihara, H ;
Coughlin, SR .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :879-887
[8]   A dual thrombin receptor system for platelet activation [J].
Kahn, ML ;
Zheng, YW ;
Huang, W ;
Bigornia, V ;
Zeng, DW ;
Moff, S ;
Farese, RV ;
Tam, C ;
Coughlin, SR .
NATURE, 1998, 394 (6694) :690-694
[9]   Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells [J].
Kaufmann, R ;
Patt, S ;
Schafberg, H ;
Kalff, R ;
Neupert, G ;
Nowak, G .
NEUROREPORT, 1998, 9 (04) :709-712
[10]   PAR 1-type thrombin receptors are involved in thrombin-induced calcium signaling in human meningioma cells [J].
Kaufmann, R ;
Patt, S ;
Kraft, R ;
Zieger, M ;
Henklein, P ;
Neupert, G ;
Nowak, G .
JOURNAL OF NEURO-ONCOLOGY, 1999, 42 (02) :131-136